"I wish that there was more info": characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants
- PMID: 33855648
- DOI: 10.1007/s10689-021-00251-3
"I wish that there was more info": characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants
Abstract
Little is known about what uncertainties patients experience after being identified to carry a pathogenic variant in a moderate-risk cancer gene as a result of undergoing multigene panel testing for cancer susceptibility. Data regarding cancer risk estimates and effectiveness of risk management strategies for these variants continues to evolve, which has the potential to evoke uncertainty. Acknowledging uncertainty during pre- and post-test discussions is imperative to helping individuals to adapt to their results. A better understanding of this population's experience of uncertainty is needed to facilitate such discussions and is the aim of the current study. Semi-structured interviews (30-60 min in length), informed by Han and colleagues' taxonomy of uncertainty in clinical genomic sequencing, were conducted to assess motivations to pursue genetic testing, areas of perceived uncertainty, and strategies for managing uncertainty among 20 carriers of pathogenic variants in two moderate-risk genes, ATM and CHEK2. We found that participants pursue genetic testing with the expectation that results will clarify cancer risks and approaches to management. Participants experience uncertainties aligning with Han's taxonomy relating to the ambiguity of specific cancer risk estimates and effectiveness of certain risk management strategies. These uncertainties influenced decisions around the uptake of risk management strategies, which were additionally impacted by clinicians' uncertainty towards such strategies. Participants employ a variety of uncertainty management approaches to cope with their anxieties. Clinicians may wish to use these findings to facilitate patient adaptation to the implications of multigene panel testing for cancer susceptibility during both pre- and post-test counseling sessions.
Keywords: ATM; CHEK2; Cancer genetics; Genetic testing; Qualitative research; Uncertainty.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model.JCO Precis Oncol. 2021 Jun 24;5:PO.20.00484. doi: 10.1200/PO.20.00484. eCollection 2021 Jun. JCO Precis Oncol. 2021. PMID: 34322652 Free PMC article.
-
Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.Fam Cancer. 2018 Oct;17(4):495-505. doi: 10.1007/s10689-018-0070-x. Fam Cancer. 2018. PMID: 29445900 Free PMC article.
-
Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers.Cancer. 2020 Apr 15;126(8):1651-1655. doi: 10.1002/cncr.32715. Epub 2020 Jan 22. Cancer. 2020. PMID: 31967672 Free PMC article.
-
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.Breast. 2022 Oct;65:32-40. doi: 10.1016/j.breast.2022.06.003. Epub 2022 Jun 18. Breast. 2022. PMID: 35772246 Free PMC article. Review.
-
Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.Expert Rev Anticancer Ther. 2015;15(11):1315-26. doi: 10.1586/14737140.2015.1090879. Epub 2015 Nov 2. Expert Rev Anticancer Ther. 2015. PMID: 26523341 Review.
Cited by
-
Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM.Breast Cancer Res. 2022 Apr 1;24(1):24. doi: 10.1186/s13058-022-01518-y. Breast Cancer Res. 2022. PMID: 35365198 Free PMC article.
-
Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening.Eur J Hum Genet. 2024 Apr;32(4):392-398. doi: 10.1038/s41431-023-01345-5. Epub 2023 Mar 27. Eur J Hum Genet. 2024. PMID: 36973394 Free PMC article.
-
"You Always Have It in the Back of Your Mind"-Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview Study.Int J Environ Res Public Health. 2022 Mar 16;19(6):3525. doi: 10.3390/ijerph19063525. Int J Environ Res Public Health. 2022. PMID: 35329227 Free PMC article.
-
A qualitative study of unaffected ATM and CHEK2 carriers: How participants make meaning of 'moderate risk' genetic results in a population breast cancer screening trial.J Genet Couns. 2022 Dec;31(6):1421-1433. doi: 10.1002/jgc4.1617. Epub 2022 Jul 25. J Genet Couns. 2022. PMID: 35877161 Free PMC article. Clinical Trial.
References
-
- Idos GE, Kurian AW, Ricker C et al (2019) Multicenter prospective cohort study of the diagnostic yield and patient experience of multiplex gene panel testing for hereditary cancer risk. JCO Precis Oncol 3:1–19. https://doi.org/10.1200/PO.18.00217 - DOI
-
- Rainville IR, Rana HQ (2014) Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep 16:371. https://doi.org/10.1007/s11912-013-0371-z - DOI - PubMed
-
- Bradbury AR, Patrick-Miller L, Long J et al (2015) Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genet Med 17:485–492. https://doi.org/10.1038/gim.2014.134 - DOI - PubMed
-
- Cybulski C, Wokołorczyk D, Jakubowska A et al (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29:3747–3752. https://doi.org/10.1200/JCO.2010.34.0778 - DOI - PubMed
-
- Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. JNCI J Natl Cancer Inst 105:812–822. https://doi.org/10.1093/jnci/djt095 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous